MICHAEL REDDY: Open Payments
NPI 1386647444 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 28 payments from 14 companies in 2025. Trend: 2023 $1,096 · 2024 $1,051 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $151 |
| TOLMAR, INC. | 4 | $83 |
| Janssen Biotech, Inc. | 3 | $55 |
| Antares Pharma, Inc. | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $20 |
Products named: LUPRON DEPOT, JATENZO, ERLEADA, XYOSTED, GIVLAARI, ADSTILADRIN, XTANDI, Axonics.
Industry payments across NY — which companies pay providers there.
